The multiple faces of nicotine and its implications in tissue and wound repair.

Albany College of Pharmacy and Health Sciences, The Pharmaceutical Research Institute, Albany, NY, USA.
Experimental Dermatology (Impact Factor: 4.12). 07/2009; 18(6):497-505. DOI: 10.1111/j.1600-0625.2009.00854.x
Source: PubMed

ABSTRACT Nicotine, one of the thousands of chemicals in cigarette smoke has a highly debated effect on cell proliferation and tissue healing. Recent studies documented its pro-angiogenesis effects by stimulating endothelial cell alpha7-non-neronal nicotinic acetyl choline receptors (alpha7 N-nACHR). It is well known that individuals who smoke or have diabetes experience impaired wound healing although for different reasons. This review evaluates several current studies relating to nicotine's ability to mediate cellular activation, migration and angiogenesis in attempts to correlate these data with nicotine's ability to repair wounds in ischaemic tissue. While its beneficial effects are still under investigation, important findings regarding nicotine's acceleration of atherosclerosis, tumor angiogenesis, cell proliferation e and resistance to apoptosis put its systemic use into question. Based on the good and bad sides of nicotine, it is recommended to restrict its utility to local applications.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The complexity of fracture repair makes it an ideal process for studying the interplay between the molecular, cellular, tissue and organ level events involved in tissue regeneration. Additionally, as fracture repair recapitulates many of the processes that occur during embryonic development, investigations of fracture repair provide insights regarding skeletal embryogenesis. Specifically, inflammation, signaling, gene expression, cellular proliferation and differentiation, osteogenesis, chondrogenesis, angiogenesis, and remodeling, represent the complex array of interdependent biological events that occur during fracture repair. Here we review studies of bone regeneration in genetically modified mouse models, during aging, following environmental exposure, and in the setting of disease that provide insights regarding the role of multi-potent cells and their regulation during fracture repair. Complementary animal models and ongoing scientific discoveries define an increasing number of molecular and cellular targets to reduce the morbidity and complications associated with fracture repair. Lastly, some new and exciting areas of stem cell research such as the contribution of mitochondria function, limb regeneration signaling and microRNA (miRNA) post-transcriptional regulation are all likely to further contribute to our understanding of fracture repair as an active branch of regenerative medicine. © 2014 American Society for Bone and Mineral Research.
    Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 09/2014; DOI:10.1002/jbmr.2373 · 6.04 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Angiogenesis can be regarded as a double-edged sword given its useful actions in repairing tissues, and secondly due to its effects in enhancing tissue damage. Angiogenesis is actually involved in the pathogenesis of disorders in which the inflammatory component is a major contributor for disease progression, such as diabetes. It is now stated that angiogenesis together with vasculogenesis partake to neovascular development. A peculiar characteristic of diabetes is the co-existence of vascular impairment and excessive angiogenesis in distinct organs. But despite this knowledge, many questions remain unanswered. Due to the importance of these systems in diabetes-associated complications, a better understanding of the molecular and cellular processes may open new mechanism-based therapeutic options. Accordingly, the available treatment strategies for diabetes management are not completely efficient, as highlighted by the elevated mortality and morbidity rates associated with this condition. Diabetic nephropathy, which may evolve to end-stage renal failure, and diabetic retinopathy that may progress to blindness are important causes of morbidity. Additionally, chronic nonhealing skin ulceration greatly impairs the quality of life of diabetic patients, resulting often in limb amputation. Cardiovascular events, in turn, are responsible for a significant number of deaths in diabetes. This review aims at highlighting the state-of-the-art in diabetic vascular complications, and comprehends the characterization of neovascular system alterations. The elucidation of the diabetic-associated angiogenic paradox is fundamental for prospecting novel therapeutic interventions. DIABETES -THE ANGIOGENIC PARADOX Diabetes mellitus (DM) is a common metabolic disease with a high and increasing prevalence worldwide. The esti-mated number of patients afflicted with diabetes, presently about 170 million people, is expected to increase and reach a pandemic rate of 366 million by the year 2030 [1]. This in-creasing incidence renders DM a leading cause of morbidity and mortality in the near future. DM causes multiple serious health complications, demanding a thorough clinical man-agement, which renders this disease already a main burden for the National Care Systems. The diabetic condition is characterized by and responsible for alterations in micro-and macrovascular beds, by inducing changes in neovascular mechanisms and impairing vascular homeostasis. However, diabetes is a paradoxal disease from the vascular point of view, since in specific organs there is an increase in neovas-cularization, as it occurs in the kidney and in the retina, whereas others present a marked inhibition of angiogenesis, as in coronary heart disease and peripheral vascular disease [2]. Despite the increasing awareness of this diabetes-associated angiogenic paradox, the molecular mechanisms driven in the distinct organs remain unclear.
    The Open Circulation & Vascular Journal 03/2012; 3(1). DOI:10.2174/1874382601003010003

Full-text (2 Sources)

Available from
Sep 18, 2014